Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Cash (2024 - 2025)

Historic Change in Cash for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $3.4 million.

  • Beta Bionics' Change in Cash fell 2342.24% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2024, which is 44860.23% up from last year.
  • Per Beta Bionics' latest filing, its Change in Cash stood at $3.4 million for Q3 2025, which was down 2342.24% from -$7.4 million recorded in Q2 2025.
  • Beta Bionics' Change in Cash's 5-year high stood at $13.0 million during Q4 2024, with a 5-year trough of -$9.0 million in Q2 2024.